PRESS RELEASES
<< Back
Xcel Brands, Inc. Announces First Quarter 2023 Results
- Company announces completion of its strategic transformation plan to shift its business model from a wholesale/production model to a modern, asset-light and highly profitable media and consumer products business model, resulting in approximately
$13 million in annual cost savings. - Company announces major new Halston licensing agreement, which will provide upfront cash payment in the second quarter 2023, and future guaranteed minimum royalties and significant minimum net sale requirements.
- Revenues for the quarter ended
March 31, 2023 , were$6.1 million , up from$4.1 million in the immediately-preceding quarter endedDecember 31, 2022 .
Strategic Transformation
In the first quarter of 2023, Xcel began to restructure its business operations by entering into new licensing agreements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s
In conjunction with the successful launch of the C Wonder Brand on HSN in March, Xcel licensed the wholesale production operations related to the brand to
For its
The Company expects the transition of its operating businesses to be completed by the end of the second quarter of 2023.
First Quarter 2023 Financial Results
Total revenue was
Net loss attributable to
Balance Sheet
The Company's balance sheet at
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details at
About
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "ongoing," "could," "estimates," "expects," "intends," "may," "appears," "suggests," "future," "likely," "goal," "plans," "potential," "projects," "predicts," "seeks," "should," "would," "guidance," "confident" or "will" or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans, and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the risks discussed in the "Risk Factors" section and elsewhere in the Company's Annual Report on form 10-K for the year ended
For further information please contact:
216-464-6400
andrew@smberger.com
Unaudited Condensed Consolidated Statements of Operations | ||||||||
(in thousands, except share and per share data) | ||||||||
For the Three Months Ended | ||||||||
2023 | 2022 | |||||||
Revenues | ||||||||
Net licensing revenue | $ | 2,222 | $ | 5,961 | ||||
Net sales | 3,828 | 2,786 | ||||||
Net revenue | 6,050 | 8,747 | ||||||
Cost of goods sold | 2,693 | 1,680 | ||||||
Gross profit | 3,357 | 7,067 | ||||||
Operating costs and expenses | ||||||||
Salaries, benefits and employment taxes | 3,465 | 4,861 | ||||||
Other selling, general and administrative expenses | 3,493 | 3,416 | ||||||
Total operating costs and expenses | 6,958 | 8,277 | ||||||
Operating loss before other expenses, including non-cash expenses | (3,601 | ) | (1,210 | ) | ||||
Other expense, including non-cash expenses | ||||||||
Depreciation and amortization | 1,797 | 1,820 | ||||||
Loss from equity method investment | 515 | - | ||||||
Other expense, including non-cash expenses | 2,312 | 1,820 | ||||||
Operating loss | (5,913 | ) | (3,030 | ) | ||||
Interest and finance expense | ||||||||
Interest expense - term loan debt | - | 708 | ||||||
Other interest and finance charges (income), net | 25 | 1 | ||||||
Total interest and finance expense | 25 | 709 | ||||||
Loss before income taxes | (5,938 | ) | (3,739 | ) | ||||
Income tax benefit | - | - | ||||||
Net loss | (5,938 | ) | (3,739 | ) | ||||
Less: Net loss attributable to noncontrolling interest | (295 | ) | (252 | ) | ||||
Net loss attributable to |
$ | (5,643 | ) | $ | (3,487 | ) | ||
Loss per share attributed to |
||||||||
Basic and diluted net loss per share | $ | (0.29 | ) | $ | (0.18 | ) | ||
Weighted average number of common shares outstanding: | ||||||||
Basic and diluted weighted average common shares outstanding | 19,633,194 | 19,571,119 | ||||||
Unaudited Condensed Consolidated Balance Sheets | ||||||||
(in thousands, except share and per share data) | ||||||||
(Unaudited) | ||||||||
Assets | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 1,612 | $ | 4,608 | ||||
Accounts receivable, net | 5,969 | 5,110 | ||||||
Inventory | 3,099 | 2,845 | ||||||
Prepaid expenses and other current assets | 1,032 | 1,457 | ||||||
Total current assets | 11,712 | 14,020 | ||||||
Non-Current Assets: | ||||||||
Property and equipment, net | 1,237 | 1,418 | ||||||
Operating lease right-of-use assets | 5,185 | 5,420 | ||||||
Trademarks and other intangibles, net | 46,130 | 47,665 | ||||||
Equity method investment | 18,680 | 19,195 | ||||||
Deferred tax assets, net | 1,107 | 1,107 | ||||||
Other assets | 110 | 110 | ||||||
Total non-current assets | 72,449 | 74,915 | ||||||
Total Assets | $ | 84,161 | $ | 88,935 | ||||
Liabilities and Equity | ||||||||
Current Liabilities: | ||||||||
Accounts payable, accrued expenses and other current liabilities | $ | 5,549 | $ | 3,958 | ||||
Accrued income taxes payable | 555 | 568 | ||||||
Accrued payroll | 477 | 416 | ||||||
Current portion of operating lease obligations | 1,395 | 1,376 | ||||||
Current portion of contingent obligations | - | 243 | ||||||
Total current liabilities | 7,976 | 6,561 | ||||||
Long-Term Liabilities: | ||||||||
Long-term portion of operating lease obligations | 5,531 | 5,839 | ||||||
Contingent obligations | 6,396 | 6,396 | ||||||
Total long-term liabilities | 11,927 | 12,235 | ||||||
Total Liabilities | 19,903 | 18,796 | ||||||
Commitments and Contingencies | ||||||||
Equity: | ||||||||
Preferred stock, |
- | - | ||||||
Common stock, |
20 | 20 | ||||||
Paid-in capital | 103,649 | 103,592 | ||||||
Accumulated deficit | (38,440 | ) | (32,797 | ) | ||||
Total Xcel Brands, Inc. stockholders' equity | 65,229 | 70,815 | ||||||
Noncontrolling interest | (971 | ) | (676 | ) | ||||
Total Equity | 64,258 | 70,139 | ||||||
Total Liabilities and Equity | $ | 84,161 | $ | 88,935 | ||||
Unaudited Condensed Consolidated Statements of Cash Flows | ||||||||
(in thousands) | ||||||||
For the Three Months Ended | ||||||||
2023 | 2022 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (5,938 | ) | $ | (3,739 | ) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
Depreciation and amortization expense | 1,797 | 1,820 | ||||||
Amortization of deferred finance costs | - | 91 | ||||||
Stock-based compensation | 57 | 32 | ||||||
Proportional share of trademark amortization of equity method investee | 515 | |||||||
Deferred income tax benefit | - | - | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (859 | ) | (1,036 | ) | ||||
Inventory | (254 | ) | (566 | ) | ||||
Prepaid expenses and other assets | 425 | 15 | ||||||
Accounts payable, accrued expenses and other current liabilities | 1,396 | 2,620 | ||||||
Cash paid in excess of rent expense | (54 | ) | (128 | ) | ||||
Net cash used in by operating activities | (2,915 | ) | (891 | ) | ||||
Cash flows from investing activities | ||||||||
Purchase of property and equipment | (81 | ) | (35 | ) | ||||
Net cash used in investing activities | (81 | ) | (35 | ) | ||||
Cash flows from financing activities | ||||||||
Proceeds from long-term debt | - | (625 | ) | |||||
Net cash used in financing activities | - | (625 | ) | |||||
Net decrease in cash, cash equivalents, and restricted cash | (2,996 | ) | (1,551 | ) | ||||
Cash, cash equivalents, and restricted cash at beginning of period | 4,608 | 5,222 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 1,612 | $ | 3,671 | ||||
Reconciliation to amounts on consolidated balance sheets: | ||||||||
Cash and cash equivalents | $ | 1,612 | $ | 3,063 | ||||
Restricted cash | - | 608 | ||||||
Total cash, cash equivalents, and restricted cash | $ | 1,612 | $ | 3,671 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid during the period for interest | $ | - | $ | 623 | ||||
Cash paid during the period for income taxes | $ | 16 | $ | - | ||||
Non-GAAP net (loss) income and non-GAAP diluted EPS are non-GAAP unaudited terms. We define non-GAAP net income as net (loss) income attributable to
Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net (loss) income attributable to
Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to our results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus, these non-GAAP measures provide supplemental information to assist investors in evaluating our financial results.
Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do.
In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this document. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.
($ in thousands) | Three Months Ended | ||||||
2023 | 2022 | ||||||
(Unaudited) | (Unaudited) | ||||||
Net loss attributable to |
$ | (5,643 | ) | $ | (3,487 | ) | |
Amortization of trademarks | 1,520 | 1,514 | |||||
Proportional share of trademark amortization of equity method investee | 515 | ||||||
Stock-based compensation | 57 | 32 | |||||
Deferred income tax benefit | - | ||||||
Non-GAAP net loss | $ | (3,551 | ) | $ | (1,941 | ) | |
Three Months Ended | |||||||
2023 | 2022 | ||||||
(Unaudited) | (Unaudited) | ||||||
Diluted loss per share | $ | (0.29 | ) | $ | (0.18 | ) | |
Amortization of trademarks | 0.08 | 0.08 | |||||
Proportional share of trademark amortization of equity method investee | 0.03 | - | |||||
Stock-based compensation | 0.00 | ||||||
Certain adjustments to provision for doubtful accounts | - | ||||||
Deferred income tax benefit | - | ||||||
Non-GAAP diluted EPS | $ | (0.18 | ) | $ | (0.10 | ) | |
Non-GAAP weighted average diluted shares | 19,633,194 | 19,571,119 | |||||
($ in thousands) | Three Months Ended | ||||||
2023 | 2022 | ||||||
(Unaudited) | (Unaudited) | ||||||
Net loss attributable to |
$ | (5,643 | ) | $ | (3,487 | ) | |
Depreciation and amortization | 1,797 | 1,820 | |||||
Proportional share of trademark amortization of equity method investee | 515 | - | |||||
Interest and finance expense | 25 | 709 | |||||
State and local franchise taxes | 21 | 36 | |||||
Stock-based compensation | 57 | 32 | |||||
Adjusted EBITDA | $ | (3,228 | ) | $ | (890 | ) | |
Source: Xcel Brands, Inc